The tumor microenvironment as a determinant of drug response and resistance.

No abstract is available for this paper.

• Publication year

  1999

• Venue

  Drug resistance updates

• Publication date

  1999-10-01

• Fields of study

  Biology, Medicine, Environmental Science

• Identifiers
  DOI 10.1054/DRUP.1999.0097PMID 11504502
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Extracellular matrix proteins protect small cell lung cancer cells against apoptosis: A mechanism for small cell lung cancer growth and drug resistance in vivo

  1999cited by this paper
• Cell Adhesion Mediated Drug Resistance (CAM-DR): Role of Integrins and Resistance to Apoptosis in Human Myeloma Cell Lines

  1999cited by this paper
• Cell adhesion mediated drug resistance (CAM-DR): role of integrins and resistance to apoptosis in human myeloma cell lines.

  1999cited by this paper
• Constitutive activation of Stat3 signaling confers resistance to apoptosis in human U266 myeloma cells.

  1999cited by this paper
• Interleukin 6 differentially potentiates the antitumor effects of taxol and vinblastine in U266 human myeloma cells.

  1998cited by this paper
• BCL-X expression in multiple myeloma: possible indicator of chemoresistance.

  1998cited by this paper
• Interleukin-6-induced inhibition of multiple myeloma cell apoptosis: support for the hypothesis that protection is mediated via inhibition of the JNK/SAPK pathway.

  1998cited by this paper
• Induction of apoptosis in human neuroblastoma cells by abrogation of integrin‐mediated cell adhesion

  1997cited by this paper
• Interleukin-6 inhibits Fas-induced apoptosis and stress-activated protein kinase activation in multiple myeloma cells.

  1997cited by this paper
• Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery.

  1997cited by this paper
• Mechanisms of drug resistance in hematologic malignancies.

  1997cited by this paper
• The PI 3-kinase/Akt signaling pathway delivers an anti-apoptotic signal.

  1997cited by this paper
• Fibronectin suppresses apoptosis in normal human melanocytes through an integrin-dependent mechanism.

  1997cited by this paper
• Regulation of eosinophil cell death by adhesion to fibronectin.

  1996cited by this paper
• Myeloma cell growth arrest, apoptosis, and interleukin-6 receptor modulation induced by EB1089, a vitamin D3 derivative, alone or in association with dexamethasone.

  1996cited by this paper
• Integrin activation suppresses etoposide-induced DNA strand breakage in cultured murine tumor-derived endothelial cells.

  1996cited by this paper
• Impact of the cyclin–dependent kinase inhibitor p27Kip1 on resistance of tumor cells to anticancer agents

  1996cited by this paper
• Interleukin-6 inhibits apoptosis of malignant plasma cells.

  1995cited by this paper
• Interleukin-6 in human multiple myeloma.

  1995cited by this paper
• Integrins and signal transduction pathways: the road taken.

  1995cited by this paper
• Interleukin-6 family of cytokines and gp130.

  1995cited by this paper
• Dexamethasone and suramin inhibit cell proliferation and interleukin-6-mediated immunoglobulin secretion in human lymphoid and multiple myeloma cell lines.

  1995cited by this paper
• The Fas death factor

  1995cited by this paper
• The alpha 5 beta 1 integrin supports survival of cells on fibronectin and up-regulates Bcl-2 expression.

  1995cited by this paper
• Prevention of myeloma cell apoptosis by ectopic bcl-2 expression or interleukin 6-mediated up-regulation of bcl-xL.

  1995cited by this paper
• Association of transcription factor APRF and protein kinase Jak1 with the interleukin-6 signal transducer gp130.

  1994cited by this paper
• Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins.

  1994cited by this paper
• Interleukin-6 prevents dexamethasone-induced myeloma cell death.

  1994cited by this paper
• IL-6-induced homodimerization of gp130 and associated activation of a tyrosine kinase.

  1993cited by this paper
• The extracellular matrix as a cell survival factor.

  1993cited by this paper
• Hematopoietic cytokines inhibit apoptosis induced by transforming growth factor beta 1 and cancer chemotherapy compounds in myeloid leukemic cells.

  1992cited by this paper
• Tumor resistance to alkylating agents conferred by mechanisms operative only in vivo.

  1990cited by this paper
• Autocrine generation and requirement of BSF-2/IL-6 for human multiple myelomas

  1988cited by this paper
• Effects of intercellular contact on repair of radiation damage.

  1972cited by this paper

• Patient‐Derived Microphysiological Systems for Precision Medicine

  2023cites this paper
• Targeting of the Interleukin-13 Receptor (IL-13R)α2 Expressing Prostate Cancer by a Novel Hybrid Lytic Peptide

  2023cites this paper
• Cancer drug resistance induced by EMT: novel therapeutic strategies

  2021cites this paper
• Tumor Immunology: Understanding the Immune System and Cancer to Enhance the Efficacy of Cancer Immunotherapies

  2021cites this paper
• Innate immune activation by checkpoint inhibition in human patient-derived lung cancer tissues

  2021cites this paper
• Advances in Drug Resistance of Esophageal Cancer: From the Perspective of Tumor Microenvironment

  2021cites this paper
• The pan-therapeutic resistance of disseminated tumor cells: role of phenotypic plasticity and the metastatic microenvironment.

  2020cites this paper
• Adipocytes: active facilitators in epithelial ovarian cancer progression?

  2020cites this paper
• Epithelial–Mesenchymal Transition Programs and Cancer Stem Cell Phenotypes: Mediators of Breast Cancer Therapy Resistance

  2020cites this paper
• Leveraging and manufacturing in vitro multicellular spheroid-based tumor cell model as a preclinical tool for translating dysregulated tumor metabolism into clinical targets and biomarkers

  2020cites this paper
• Fabrication of a novel hierarchical fibrous scaffold for breast cancer cell culture

  2019cites this paper
• Dissecting the m6A methylation affection on afatinib resistance in non-small cell lung cancer

  2019cites this paper
• THE ROLE OF THE TUMOR MICROENVIRONMENT IN WALDENSTRÖM MACROGLOBULINEMIA

  2019cites this paper
• Aiding and Abetting: How the Tumor Microenvironment Protects Cancer from Chemotherapy

  2019cites this paper
• The IncRNA BORG: A novel inducer of TNBC metastasis, chemoresistance, and disease recurrence.

  2019cites this paper
• A Theranostic Nanoprobe for Hypoxia Imaging and Photodynamic Tumor Therapy

  2019cites this paper
• Yin and Yang of Pluripotency: Results of Analysis of Genes Overexpressed In Tumor-Initiating Cells of Krebs-2 Ascites Carcinoma

  2019cites this paper
• The Role of Matrix Gla Protein (MGP) Expression in Paclitaxel and Topotecan Resistant Ovarian Cancer Cell Lines

  2018cites this paper
• An extracellular matrix (ECM) model at high malignant colorectal tumor increases chondroitin sulfate chains to promote epithelial‐mesenchymal transition and chemoresistance acquisition

  2018cites this paper
• Cancer Stem Cells: Emergent Nature of Tumor Emergency

  2018cites this paper
• 3D tumor spheroids as in vitro models to mimic in vivo human solid tumors resistance to therapeutic drugs

  2018cites this paper
• Musculoskeletal Metastasis from Primary Rectal Cancer: Series of Two Cases of a Very Rare Occurrence with a Short Literature Review

  2018cites this paper
• Nanotoxicity in cancer research: technical protocols and tips considerations for the use of 3D tumour spheroids

  2017cites this paper
• The cancer cell adhesion resistome: mechanisms, targeting and translational approaches

  2017cites this paper
• Biomaterials based strategies for engineering tumor microenvironment

  2017cites this paper
• Increased Expression of Several Collagen Genes is Associated with Drug Resistance in Ovarian Cancer Cell Lines

  2016influential citation
• Leveraging Hypoxia-Activated Prodrugs to Prevent Drug Resistance in Solid Tumors

  2016cites this paper
• Decellularized matrices as in vitro models of extracellular matrix in tumor tissues at different malignant levels: Mechanism of 5-fluorouracil resistance in colorectal tumor cells.

  2016cites this paper
• An individualised signature for predicting response with concordant survival benefit for lung adenocarcinoma patients receiving platinum-based chemotherapy

  2016cites this paper
• Colorectal cancer: Metastases to a single organ 2015 Advances in Colorectal

  2015cites this paper
• Silencing of DYRK2 increases cell proliferation but reverses CAM-DR in Non-Hodgkin's Lymphoma.

  2015cites this paper
• Colorectal cancer: Metastases to a single organ.

  2015cites this paper
• Extracellular Matrix Proteins Expression Profiling in Chemoresistant Variants of the A2780 Ovarian Cancer Cell Line

  2014cites this paper
• Microarray-based detection and expression analysis of extracellular matrix proteins in drug‑resistant ovarian cancer cell lines.

  2014cites this paper
• Development of a novel preclinical pancreatic cancer research model: bioluminescence image-guided focal irradiation and tumor monitoring of orthotopic xenografts.

  2012cites this paper
• Recherche de biomarqueurs des cellules propagatrices de glioblastome : étude de la signalisation calcique et du protéome membranaire

  2012cites this paper
• Fibroblast growth factor-2, chemoresistance and colorectal cancer

  2012cites this paper
• Stromal–epithelial interactions modulate cross-talk between prolactin receptor and HER2/Neu in breast cancer

  2012cites this paper
• Targeting EGFR for treatment of glioblastoma: molecular basis to overcome resistance.

  2012cites this paper
• Homo sapiens Systemic RNA Interference-defective-1 Transmembrane Family Member 1 (SIDT1) Protein Mediates Contact-dependent Small RNA Transfer and MicroRNA-21-driven Chemoresistance*

  2011cites this paper
• Tissue slice model of human lung cancer to investigate telomerase inhibition by nanoparticle delivery of antisense 2'-O-methyl-RNA.

  2011cites this paper
• Bioengineering approaches to study multidrug resistance in tumor cells.

  2011cites this paper
• Mathematical model of the role of intercellular signalling in intercellular cooperation during tumorigenesis

  2011cites this paper
• Hepatocyte growth factor (HGF), heat shock proteins (HSPs) and multidrug resistance protein (MRP) expression in co-culture of colon tumor spheroids with normal cells after incubation with interleukin-1beta (IL-1beta) and/or camptothecin (CPT-11).

  2010cites this paper
• In vivo bioluminescent imaging of irradiated orthotopic pancreatic cancer xenografts in nonobese diabetic-severe combined immunodeficient mice: a novel method for targeting and assaying efficacy of ionizing radiation.

  2010cites this paper
• Expression of HSP27, HSP72 and MRP proteins in in vitro co-culture of colon tumour cell spheroids with normal cells after incubation with rhTGF-β1 and/or CPT-11

  2009influential citation
• Identification of a novel switch in the dominant forms of cell adhesion-mediated drug resistance in glioblastoma cells

  2008cites this paper
• Adhesion of Beta 1 Integrin to Fibronectin Regulates CAM-DR Phenotype via p 21 WAF 1 / cip 1 in HL 60 Acute Myeloid Leukemia ( AML ) Cells

  2008cites this paper
• Metastasis: a therapeutic target for cancer

  2008cites this paper
• INHIBITION OF PHOSPHATIDYLINOSITOL 3-KINASE (PI3K) SIGNALLING LEADS TO RESISTANCE TO CHEMOTHERAPEUTIC AGENTS IN HUMAN CANCER CELLS

  2008cites this paper
• Adhesion of Beta1 Integrin to Fibronectin Regulates CAM-DR Phenotype via p21 WAF1/cip1 in HL60 Acute Myeloid Leukemia (AML) Cells

  2008cites this paper
• Überprüfung neuer Therapieansätze für Patched- assoziierte Tumoren im Mausmodell

  2008cites this paper
• Interaction between CD44 and hyaluronate induces chemoresistance in non-small cell lung cancer cell.

  2007cites this paper
• Anticancer therapeutics: a surge of new developments increasingly target tumor and stroma.

  2007cites this paper
• Apoptosis and chemo‐resistance in colorectal cancer

  2007cites this paper
• Effects of Collagen IV on Cisplatin-Induced Apoptosis of Non-Small Cell Lung Cancer Cells

  2007influential citation
• Myeloma Cells and Their Interactions With the Bone Marrow Endothelial Cells

  2007cites this paper
• Gene expression response to cisplatin treatment in drug-sensitive and drug-resistant ovarian cancer cells

  2007cites this paper
• Identification of molecular determinants of tumor sensitivity and resistance to anticancer drugs.

  2007cites this paper
• The Microenvironment and Drug Resistance

  2006cites this paper
• Normalizing the bone marrow microenvironment with p38 inhibitor reduces multiple myeloma cell proliferation and adhesion and suppresses osteoclast formation.

  2006cites this paper
• Tumor metastasis: mechanistic insights and clinical challenges

  2006cites this paper
• Tumor dormancy and the role of metastasis suppressor genes in regulating ectopic growth.

  2006cites this paper
• Expression of Collagen IV, Fibronectin, Laminin in Non-small Cell Lung Cancer and Its Correlation with Chemosensitivities and Apoptosis~*

  2006cites this paper
• Role of Tumour Microenvironment in Chemoresistance

  2005cites this paper
• Perspectives for combination therapy to overcome drug-resistant multiple myeloma.

  2005cites this paper
• Integrins as a distinct subtype of dependence receptors

  2005cites this paper
• Role of the extracellular matrix proteins in the resistance of SP6.5 uveal melanoma cells toward cisplatin.

  2005cites this paper
• Development and Evaluation of a Skin Organ Model for the Analysis of Radiation Effects

  2004cites this paper
• Targeting the bone marrow microenvironment in hematologic malignancies.

  2004cites this paper
• Therapeutic targets for antimetastatic therapy

  2004cites this paper
• Molecular mechanisms of platinum resistance: still searching for the Achilles' heel.

  2004cites this paper
• Three-dimensional culture system as a model for studying cancer cell invasion capacity and anticancer drug sensitivity.

  2004cites this paper
• Metastasis suppressor genes: basic biology and potential clinical use.

  2003cites this paper
• Remodeling of the extracellular matrix through overexpression of collagen VI contributes to cisplatin resistance in ovarian cancer cells.

  2003cites this paper
• Drug resistance and the microenvironment: nature and nurture.

  2003cites this paper
• Resistance to cytotoxic and anti-angiogenic anticancer agents: similarities and differences.

  2003cites this paper
• The use of cyclin-dependent kinase inhibitors alone or in combination with established cytotoxic drugs in cancer chemotherapy.

  2003cites this paper
• New Technology for Deep Light Distribution in Tissue for Phototherapy

  2002cites this paper
• Cancer research 2001: drug resistance, new targets and drug combinations.

  2001cites this paper
• Multiple myeloma.

  2001cites this paper
• Multiple myeloma

  2001cites this paper
• In vivo veritas: Bcl-2 and Bcl-X(L)mediate tumor cell resistance to chemotherapy.

  2000cites this paper
• Multiple Myeloma: New Insights and Therapeutic Approaches.

  2000cites this paper
• MULTIPLE MYELOMA

  1931cites this paper
• Edinburgh Research Explorer Homo sapiens Systemic RNA Interference-defective-1 Transmembrane Family Member 1 (SIDT1) Protein Mediates Contact-dependent Small RNA Transfer and MicroRNA-21-driven Chemoresistance

  year unknowncites this paper